Ronald W. Penczek - Mar 1, 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Mar 1, 2023
Transactions value $
-$208,154
Form type
4
Date filed
3/3/2023, 03:28 PM
Previous filing
Mar 3, 2022
Next filing
Oct 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Tax liability -$30K -64 -3.34% $469.03 1.85K Mar 1, 2023 Direct F1
transaction ELV Common Stock Award $0 +214 +11.55% $0.00 2.07K Mar 1, 2023 Direct F2
transaction ELV Common Stock Award $0 +1.2K +57.81% $0.00 3.26K Mar 1, 2023 Direct F3
transaction ELV Common Stock Tax liability -$178K -380 -11.65% $468.78 2.88K Mar 2, 2023 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award $0 +819 $0.00 819 Mar 1, 2023 Common Stock 819 $469.03 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2 Represents restricted share units. Restrictions lapse as follows: 71 shares each on 3/1/2024 and 3/1/2025 and 72 shares on 3/1/2026.
F3 Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
F4 Balance includes 3.60 shares acquired on March 25, 2022, 3.67 shares acquired on June 24, 2022, 3.80 shares acquired on September 23, 2022 and 3.46 shares acquired on December 21, 2022 through a dividend reinvestment plan.
F5 The option represents a right to purchase a total of 819 shares, and is exercisable in three installments of 273 shares each, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.